Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Motor Evoked Potentials as Potential Biomarkers of Early Atypical Corticospinal Tract Development in Infants with Perinatal Stroke.

Kowalski JL, Nemanich ST, Nawshin T, Chen M, Peyton C, Zorn E, Hickey M, Rao R, Georgieff M, Rudser K, Gillick BT.

J Clin Med. 2019 Aug 13;8(8). pii: E1208. doi: 10.3390/jcm8081208.

2.

Is There a Role for Natural Antibodies in Rejection Following Transplantation?

Zorn E, See SB.

Transplantation. 2019 Aug;103(8):1612-1619. doi: 10.1097/TP.0000000000002743.

PMID:
30951015
3.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
4.

Safety and Feasibility of Transcranial Magnetic Stimulation as an Exploratory Assessment of Corticospinal Connectivity in Infants After Perinatal Brain Injury: An Observational Study.

Nemanich ST, Chen CY, Chen M, Zorn E, Mueller B, Peyton C, Elison JT, Stinear J, Rao R, Georgieff M, Menk J, Rudser K, Gillick B.

Phys Ther. 2019 Jun 1;99(6):689-700. doi: 10.1093/ptj/pzz028.

PMID:
30806664
5.

Effector B cells in cardiac allograft vasculopathy.

Zorn E.

Curr Opin Organ Transplant. 2019 Feb;24(1):31-36. doi: 10.1097/MOT.0000000000000591.

PMID:
30480642
6.

Preserved speed of processing and memory in infants with a history of moderate neonatal encephalopathy treated with therapeutic hypothermia.

Zorn EP, Zhang L, Sandness K, Miller N, Riggins T, Georgieff MK, Pfister KM.

J Perinatol. 2018 Dec;38(12):1666-1673. doi: 10.1038/s41372-018-0253-1. Epub 2018 Oct 15.

PMID:
30323324
7.

New insights on innate B-cell immunity in transplantation.

Zorn E.

Xenotransplantation. 2018 May;25(3):e12417. doi: 10.1111/xen.12417. Review.

8.

Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival.

See SB, Aubert O, Loupy A, Veras Y, Lebreton X, Gao B, Legendre C, Anglicheau D, Zorn E.

J Am Soc Nephrol. 2018 Jun;29(6):1761-1770. doi: 10.1681/ASN.2017111157. Epub 2018 Mar 30.

9.

Comparative Assessment of Anti-HLA Antibodies Using Two Commercially Available Luminex-Based Assays.

Clerkin KJ, See SB, Farr MA, Restaino SW, Serban G, Latif F, Li L, Colombo PC, Vlad G, Ray B, Vasilescu ER, Zorn E.

Transplant Direct. 2017 Oct 2;3(11):e218. doi: 10.1097/TXD.0000000000000734. eCollection 2017 Nov.

10.

Robust real-time cell analysis method for determining viral infectious titers during development of a viral vaccine production process.

Charretier C, Saulnier A, Benair L, Armanet C, Bassard I, Daulon S, Bernigaud B, Rodrigues de Sousa E, Gonthier C, Zorn E, Vetter E, Saintpierre C, Riou P, Gaillac D.

J Virol Methods. 2018 Feb;252:57-64. doi: 10.1016/j.jviromet.2017.11.002. Epub 2017 Nov 14.

11.

Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.

Chatterjee D, Moore C, Gao B, Clerkin KJ, See SB, Shaked D, Rogers K, Nunez S, Veras Y, Addonizio L, Givertz MM, Naka Y, Mancini D, Vasilescu R, Marboe C, Restaino S, Madsen JC, Zorn E.

J Heart Lung Transplant. 2018 Mar;37(3):385-393. doi: 10.1016/j.healun.2017.09.011. Epub 2017 Sep 28.

12.

Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection.

Kennel PJ, Saha A, Maldonado DA, Givens R, Brunjes DL, Castillero E, Zhang X, Ji R, Yahi A, George I, Mancini DM, Koller A, Fine B, Zorn E, Colombo PC, Tatonetti N, Chen EI, Schulze PC.

J Heart Lung Transplant. 2018 Mar;37(3):409-417. doi: 10.1016/j.healun.2017.07.012. Epub 2017 Jul 19.

PMID:
28789823
13.

New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report.

Dieudé M, West LJ, Muruve DA, Gunaratnam L, Mohanakumar T, Zorn E, Cairo CW, Freed DH, Schultz KR, Fairchild RL, Hébert MJ.

Transplantation. 2018 Feb;102(2):209-214. doi: 10.1097/TP.0000000000001872. Review. Erratum in: Transplantation. 2018 Jul;102(7):e360. Gunaratman, Lakshman [corrected to Gunaratnam, Lakshman].

14.

The human thymus perivascular space is a functional niche for viral-specific plasma cells.

Nuñez S, Moore C, Gao B, Rogers K, Hidalgo Y, Del Nido PJ, Restaino S, Naka Y, Bhagat G, Madsen JC, Bono MR, Zorn E.

Sci Immunol. 2016 Dec;1(6). pii: eaah4447. doi: 10.1126/sciimmunol.aah4447. Epub 2016 Dec 23.

15.

Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.

See SB, Clerkin KJ, Kennel PJ, Zhang F, Weber MP, Rogers KJ, Chatterjee D, Vasilescu ER, Vlad G, Naka Y, Restaino SW, Farr MA, Topkara VK, Colombo PC, Mancini DM, Schulze PC, Levin B, Zorn E.

J Heart Lung Transplant. 2017 Aug;36(8):862-870. doi: 10.1016/j.healun.2017.03.018. Epub 2017 Mar 24.

16.

Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients.

Gao B, Gu Y, Rong C, Moore C, Porcheray F, Wong W, Preffer F, Saidman SL, Fu Y, Cosimi B, Sachs DH, Kawai T, Sykes M, Zorn E.

Transplantation. 2017 Nov;101(11):2722-2730. doi: 10.1097/TP.0000000000001789.

17.

Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance.

Sprangers B, DeWolf S, Savage TM, Morokata T, Obradovic A, LoCascio SA, Shonts B, Zuber J, Lau SP, Shah R, Morris H, Steshenko V, Zorn E, Preffer FI, Olek S, Dombkowski DM, Turka LA, Colvin R, Winchester R, Kawai T, Sykes M.

Am J Transplant. 2017 Aug;17(8):2020-2032. doi: 10.1111/ajt.14251. Epub 2017 Apr 10.

18.

Polyreactive natural antibodies in transplantation.

Zorn E, See SB.

Curr Opin Organ Transplant. 2017 Feb;22(1):8-13. doi: 10.1097/MOT.0000000000000376. Review.

PMID:
28005572
19.

Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.

Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC, Colombo PC, Mancini DM.

J Heart Lung Transplant. 2017 May;36(5):540-545. doi: 10.1016/j.healun.2016.10.016. Epub 2016 Nov 17.

20.

The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.

Clerkin KJ, Restaino SW, Zorn E, Vasilescu ER, Marboe CC, Mancini DM.

J Heart Lung Transplant. 2016 Sep;35(9):1059-66. doi: 10.1016/j.healun.2016.04.007. Epub 2016 May 6.

21.

Correlation of MRI Brain Injury Findings with Neonatal Clinical Factors in Infants with Congenital Diaphragmatic Hernia.

Radhakrishnan R, Merhar S, Meinzen-Derr J, Haberman B, Lim FY, Burns P, Zorn E, Kline-Fath B.

AJNR Am J Neuroradiol. 2016 Sep;37(9):1745-51. doi: 10.3174/ajnr.A4787. Epub 2016 May 5.

22.

Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.

Gao B, Rong C, Porcheray F, Moore C, Girouard TC, Saidman SL, Wong W, Fu Y, Zorn E.

Transplantation. 2016 Jan;100(1):217-26. doi: 10.1097/TP.0000000000000840.

23.

Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys.

Yamada Y, Nadazdin O, Boskovic S, Lee S, Zorn E, Smith RN, Colvin RB, Madsen JC, Cosimi AB, Kawai T, Benichou G.

Am J Transplant. 2015 Dec;15(12):3055-66. doi: 10.1111/ajt.13382. Epub 2015 Jul 17.

24.

Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

Zuber J, Rosen S, Shonts B, Sprangers B, Savage TM, Richman S, Yang S, Lau SP, DeWolf S, Farber D, Vlad G, Zorn E, Wong W, Emond J, Levin B, Martinez M, Kato T, Sykes M.

Am J Transplant. 2015 Oct;15(10):2691-703. doi: 10.1111/ajt.13325. Epub 2015 May 18.

25.

Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss.

Gao B, Moore C, Porcheray F, Rong C, Abidoglu C, DeVito J, Paine R, Girouard TC, Saidman SL, Schoenfeld D, Levin B, Wong W, Elias N, Schuetz C, Rosales I, Fu Y, Zorn E.

Am J Transplant. 2014 Jul;14(7):1581-91. doi: 10.1111/ajt.12763. Epub 2014 Jun 16.

26.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB.

Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.

27.

Expansion and somatic hypermutation of B-cell clones in rejected human kidney grafts.

Ferdman J, Porcheray F, Gao B, Moore C, DeVito J, Dougherty S, Thomas MV, Farkash EA, Elias N, Kawai T, Malek SK, Tullius SG, Wong W, Zorn E.

Transplantation. 2014 Oct 15;98(7):766-72. doi: 10.1097/TP.0000000000000124.

28.

AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation.

Mengel M, Chong A, Rothstein DM, Zorn E, Maltzman JS.

Am J Transplant. 2014 Mar;14(3):524-30. doi: 10.1111/ajt.12593. Epub 2014 Jan 24.

29.

Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Porcheray F, Fraser JW, Gao B, McColl A, DeVito J, Dargon I, Helou Y, Wong W, Girouard TC, Saidman SL, Colvin RB, Palmisano A, Maggiore U, Vaglio A, Smith RN, Zorn E.

Am J Transplant. 2013 Oct;13(10):2590-600. doi: 10.1111/ajt.12394. Epub 2013 Aug 6.

30.

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Smith RN, Malik F, Goes N, Farris AB, Zorn E, Saidman S, Tolkoff-Rubin N, Puri S, Wong W.

Transpl Immunol. 2012 Oct;27(2-3):107-13. doi: 10.1016/j.trim.2012.08.005. Epub 2012 Aug 30.

31.

Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection.

Porcheray F, DeVito J, Helou Y, Dargon I, Fraser JW, Nobecourt P, Ferdman J, Germana S, Girouard TC, Kawai T, Saidman SL, Wong W, Colvin RB, Leguern C, Zorn E.

Am J Transplant. 2012 Aug;12(8):2088-97. doi: 10.1111/j.1600-6143.2012.04053.x. Epub 2012 Apr 17.

32.

Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.

Porcheray F, Miklos DB, Floyd BH, Sarantopoulos S, Bellucci R, Soiffer RJ, Antin JH, Alyea EP, Ritz J, Zorn E.

Transplantation. 2011 Aug 15;92(3):359-65. doi: 10.1097/TP.0b013e3182244cc3.

33.

Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine.

Wong W, DeVito J, Nguyen H, Sarracino D, Porcheray F, Dargon I, Pelle PD, Collins AB, Tolkoff-Rubin N, Smith RN, Colvin R, Zorn E.

Am J Transplant. 2010 Nov;10(11):2463-71. doi: 10.1111/j.1600-6143.2010.03290.x.

34.

Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.

Porcheray F, DeVito J, Yeap BY, Xue L, Dargon I, Paine R, Girouard TC, Saidman SL, Colvin RB, Wong W, Zorn E.

Transplantation. 2010 May 27;89(10):1239-46. doi: 10.1097/TP.0b013e3181d72091.

35.

B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Porcheray F, Wong W, Saidman SL, De Vito J, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E.

Am J Transplant. 2009 Sep;9(9):2126-35. doi: 10.1111/j.1600-6143.2009.02738.x. Epub 2009 Jul 16.

36.

Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.

Zorn E, Mohseni M, Kim H, Porcheray F, Lynch A, Bellucci R, Canning C, Alyea EP, Soiffer RJ, Ritz J.

Biol Blood Marrow Transplant. 2009 Mar;15(3):382-8. doi: 10.1016/j.bbmt.2008.12.494.

37.

Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports.

Wong W, Lee RA, Saidman SL, Smith RN, Zorn E.

Clin Transpl. 2009:401-5.

38.

Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.

Moreau AS, Sebti Y, Duhamel A, Roccaro AM, Coiteux V, Gastinne T, Le Friec G, Burwick N, Amiot L, Ho AW, Poulain S, Hennache B, Hunter ZR, Dessaint JP, Ghobrial IM, Treon SP, Facon T, Zorn E, Leleu X.

Eur J Haematol. 2008 Jun;80(6):503-9. doi: 10.1111/j.1600-0609.2008.01060.x. Epub 2008 Mar 10.

PMID:
18331603
39.

Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.

Dellas K, Bache M, Pigorsch SU, Taubert H, Kappler M, Holzapfel D, Zorn E, Holzhausen HJ, Haensgen G.

Strahlenther Onkol. 2008 Mar;184(3):169-74. doi: 10.1007/s00066-008-1764-z.

PMID:
18330514
40.

A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.

Podar K, Gouill SL, Zhang J, Opferman JT, Zorn E, Tai YT, Hideshima T, Amiot M, Chauhan D, Harousseau JL, Anderson KC.

Oncogene. 2008 Jan 31;27(6):721-31. Epub 2007 Jul 23.

PMID:
17653083
41.

Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.

Bellucci R, Oertelt S, Gallagher M, Li S, Zorn E, Weller E, Porcheray F, Alyea EP, Soiffer RJ, Munshi NC, Gershwin ME, Ritz J.

Blood. 2007 Mar 1;109(5):2001-7. Epub 2006 Oct 26.

42.

Studying human regulatory T cells in vivo.

Zorn E, Ritz J.

Clin Cancer Res. 2006 Sep 15;12(18):5265-7. Review. No abstract available.

43.

Building the bridge: helping nurse leaders find a vision through art.

Zorn E.

Beginnings. 2006 Summer;26(3):28-9. No abstract available.

PMID:
16764195
44.

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, Bellucci R, Raderschall E, Canning C, Soiffer RJ, Frank DA, Ritz J.

Blood. 2006 Sep 1;108(5):1571-9. Epub 2006 Apr 27.

45.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

Schultz KR, Miklos DB, Fowler D, Cooke K, Shizuru J, Zorn E, Holler E, Ferrara J, Shulman H, Lee SJ, Martin P, Filipovich AH, Flowers ME, Weisdorf D, Couriel D, Lachenbruch PA, Mittleman B, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2006 Feb;12(2):126-37.

46.

CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.

Zorn E.

Semin Cancer Biol. 2006 Apr;16(2):150-9. Epub 2006 Jan 23. Review.

PMID:
16431128
47.

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Bellucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J.

Blood. 2005 Oct 15;106(8):2903-11. Epub 2005 Jun 21.

48.

Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.

Bellucci R, Alyea EP, Chiaretti S, Wu CJ, Zorn E, Weller E, Wu B, Canning C, Schlossman R, Munshi NC, Anderson KC, Ritz J.

Blood. 2005 May 15;105(10):3945-50. Epub 2005 Feb 3.

49.

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, Hochberg EP, Wu CJ, Alyea EP, Cutler C, Ho V, Soiffer RJ, Antin JH, Ritz J.

Blood. 2005 Apr 1;105(7):2973-8. Epub 2004 Dec 21.

50.

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.

Zorn E, Miklos DB, Floyd BH, Mattes-Ritz A, Guo L, Soiffer RJ, Antin JH, Ritz J.

J Exp Med. 2004 Apr 19;199(8):1133-42.

Supplemental Content

Support Center